tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

OPT Stock Latest News

Optimistic Outlook and Buy Rating for Opthea Limited Amid Promising Phase 3 Trials and Strong Financial Position
RatingsOptimistic Outlook and Buy Rating for Opthea Limited Amid Promising Phase 3 Trials and Strong Financial Position
3d ago
OPT
Opthea completes COAST final week 52 patient visit
PremiumThe Fly
Opthea completes COAST final week 52 patient visit
3d ago
OPT
Opthea Completes Key Phase 3 Trial Milestone in Wet AMD Treatment
PremiumCompany Announcements
Opthea Completes Key Phase 3 Trial Milestone in Wet AMD Treatment
3d ago
6K
OPT
Opthea Unveils Promising Wet AMD Therapy at Investor Day
PremiumCompany Announcements
Opthea Unveils Promising Wet AMD Therapy at Investor Day
24d ago
6K
OPT
Opthea’s Innovative Approach to AMD Treatment with Sozinibercept
PremiumCompany Announcements
Opthea’s Innovative Approach to AMD Treatment with Sozinibercept
1M ago
6K
OPT
Opthea to host investor days in New York, Australia
PremiumThe FlyOpthea to host investor days in New York, Australia
1M ago
OPT
Opthea announces publication on Phase 1b trial of sozinibercept in DME
Premium
The Fly
Opthea announces publication on Phase 1b trial of sozinibercept in DME
2M ago
OPT
Opthea to Present Phase 3 Trial Update at J.P. Morgan Healthcare Conference
Premium
Company Announcements
Opthea to Present Phase 3 Trial Update at J.P. Morgan Healthcare Conference
2M ago
6K
OPT
Opthea Highlights Innovative Wet AMD Therapy
PremiumCompany Announcements
Opthea Highlights Innovative Wet AMD Therapy
3M ago
6K
OPT
Opthea Limited to Engage Investors at Healthcare Conference
PremiumCompany Announcements
Opthea Limited to Engage Investors at Healthcare Conference
3M ago
6K
OPT
Opthea Limited Targets AMD Market with Sozinibercept
PremiumCompany Announcements
Opthea Limited Targets AMD Market with Sozinibercept
3M ago
6K
OPT
Opthea appoints Kathy Connell to board of directors
PremiumThe Fly
Opthea appoints Kathy Connell to board of directors
3M ago
OPT
Opthea Limited Strengthens Leadership and Advances AMD Treatment
PremiumCompany AnnouncementsOpthea Limited Strengthens Leadership and Advances AMD Treatment
4M ago
6K
OPT
Opthea executive director Megan Baldwin to retire from board
Premium
The Fly
Opthea executive director Megan Baldwin to retire from board
4M ago
OPT
Opthea Advances Retinal Disease Treatments
Premium
Company Announcements
Opthea Advances Retinal Disease Treatments
5M ago
6K
OPT
Opthea Advances nAMD Treatment with Sozinibercept
PremiumCompany Announcements
Opthea Advances nAMD Treatment with Sozinibercept
5M ago
6K
OPT
Opthea completes drug substance PPQ campaign for sozinibercept
PremiumThe Fly
Opthea completes drug substance PPQ campaign for sozinibercept
5M ago
OPT
Opthea Advances Toward Sozinibercept Commercialization
PremiumCompany Announcements
Opthea Advances Toward Sozinibercept Commercialization
5M ago
6K
OPT
JMP Securities healthcare analysts hold an analyst/industry conference call
PremiumThe Fly
JMP Securities healthcare analysts hold an analyst/industry conference call
5M ago
OPT
ABBV
Opthea price target lowered to $10 from $12 at Citi
PremiumThe FlyOpthea price target lowered to $10 from $12 at Citi
5M ago
OPT
Opthea to have presence at 24th EURETINA Congress
Premium
The Fly
Opthea to have presence at 24th EURETINA Congress
5M ago
OPT
Opthea’s Sozinibercept Eyes Breakthrough in AMD Therapy
Premium
Company Announcements
Opthea’s Sozinibercept Eyes Breakthrough in AMD Therapy
5M ago
6K
OPT

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >